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Magnitude and Characteristics of Patients Who Survived an Acute
Myocardial Infarction
Mayra Tisminetzky, MD, PhD; Tracy Y. Wang, MD, MHS, MSc; Jerry Gurwitz, MD; Lisa A. Kaltenbach, MS; David McManus, MD, MSCI;
Joel Gore, MD; Eric Peterson, MD; Robert J. Goldberg, PhD
Background-—The purpose of this study was to describe the magnitude and characteristics of patients who did not experience any
signiﬁcant major adverse cardiovascular event early (within 6 weeks) and late (during the ﬁrst year) after hospital discharge for an
acute myocardial infarction (AMI).
Methods and Results-—Data from 12 243 patients discharged after an AMI from 233 sites across the United States in the
TRANSLATE-ACS (Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute
Coronary Syndrome) study were analyzed. Multivariable adjusted regression analyses modeled factors associated with 6-week and
1-year survivors who did not experience a recurrent AMI, stroke, unplanned coronary revascularization, or rehospitalization for
unstable angina/chest pain during these time periods. The average age of this study population was 60.0 years, 72.0% were men,
and 87.9% were white. In this population, 92.4% were classiﬁed as early low-risk survivors and 76.3% were classiﬁed as late low-
risk survivors of an AMI. Factors associated with being an early and late postdischarge survivor included being male and having
single-vessel coronary artery disease at the patient’s index hospitalization. Patients who were not ﬁrst seen with any chronic health
condition, had an index hospital stay of ≤3 days, and had high baseline quality-of-life scores were more likely to be late low-risk
survivors.
Conclusions-—Identifying low-risk survivors of an AMI may permit healthcare providers to focus more intensive efforts and
interventions on those at higher risk of experiencing adverse cardiovascular events during the postdischarge transition period.
Clinical Trial Registration-—URL: http://www.clinicaltrials.gov. Unique identiﬁer: NCT01088503. ( J Am Heart Assoc. 2017;6:
e006373. DOI: 10.1161/JAHA.117.006373.)
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A s the number of Americans who survive an acutemyocardial infarction (AMI) increases,1 it is of consid-
erable clinical and public health importance to obtain
contemporary information about who represents a “low-risk”
AMI survivor and the magnitude of this patient population. In
the context of limited healthcare resources, the goal would be
to focus resources on patients who need more intensive
treatment and surveillance efforts, including those who have
survived a recent acute coronary event. Much of the current
literature that has examined the characteristics of those who
survived a recent AMI has focused on the impact of
conventional risk and prognostic factors, such as cigarette
smoking, obesity, physical inactivity, and elevated blood
pressure, on in-hospital and postdischarge survival.2–6 Few
contemporary studies have, however, described the charac-
teristics and role of other risk factors for major adverse
cardiovascular events, including depression, functional status,
or quality of transitional care after hospital discharge for an
AMI, in relation to postdischarge prognosis, overall or at
varying time points.7–11 Many psychosocial, cognitive, or
functional status indicators are not reported in clinical trials or
observational studies of patients with acute coronary disease.
Inasmuch, their association with clinically relevant outcomes,
such as death, recurrent AMI, stroke, an unplanned coronary
revascularization, and/or readmission to the hospital because
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of chest pain/unstable angina, has seldom been explored.12
The TRANSLATE-ACS (Treatment With Adenosine Diphosphate
(ADP) Receptor Inhibitors: Longitudinal Assessment of Treat-
ment Patterns and Events After Acute Coronary Syndrome)
study13 is a large observational investigation of patients
hospitalized with AMI who underwent a percutaneous coro-
nary intervention at >200 medical centers throughout the
United States. The study collected information on a broad
array of sociodemographic, clinical, and psychosocial factors
in this patient population. In this article, we describe the
likelihood and characteristics of patients in this study who did
not experience any signiﬁcant major adverse cardiovascular
event within the ﬁrst 6 weeks (early period) and during the
ﬁrst year (late period) after hospital discharge for an AMI.
Methods
TRANSLATE-ACS is a longitudinal observational study of
patients with AMI who were treated with a percutaneous
coronary intervention and antiplatelet therapy at 233 partic-
ipating medical centers between April 2010 and May 2012.
The design and conduct of this clinical/epidemiologic study,
including a detailed description of patient follow-up and data
collection activities, have been previously described.13 In
brief, this study included patients who were hospitalized with
either an ST-segment elevation myocardial infarction (STEMI)
or a non-STEMI, treated with a percutaneous coronary
intervention, and started to receive an ADP receptor inhibitor
during their index hospitalization. The institutional review
board of each enrolling hospital approved participation in
TRANSLATE-ACS, and all data were collected prospectively.
Subjects gave informed consent.
Participating hospitals collected information on patient’s
baseline demographic and clinical characteristics, processes
of care, and in-hospital outcomes using a standardized set of
data elements and deﬁnitions, aligned with those used by the
National Cardiovascular Data Registry.13 Postdischarge study
follow-up was conducted via centralized telephone interviews
at 6 weeks, 6 months, and 12 months by trained personnel
at the Duke Clinical Research Institute (Durham, North
Carolina). At each interview, patients were asked to report
any hospitalizations since their index hospital discharge or
last telephone interview. All self-reported rehospitalizations
were veriﬁed by the collection of hospital bills and medical
records. As a safeguard against underreporting, all enrolling
hospitals were queried at 12 months for any rehospitaliza-
tions that may not have been reported by the patient. In
addition, information on medication use, self-reported ﬁnan-
cial hardship with medications, quality of life, and follow-up
care was collected during telephone interviews using a
standardized questionnaire.13 We assessed functional status
at baseline using the validated EuroQol-5 Dimensions score,14
whereas symptoms of depression were assessed using the
Patient Health Questionnaire-2.15
We created a cumulative primary study end point aggre-
gating the following 5 individual postdischarge outcomes:
death, recurrent AMI, stroke, an unplanned coronary revas-
cularization, and readmission to the hospital because of chest
pain/unstable angina. End points were assessed early (within
the ﬁrst 6 weeks) and later (within 1 year) after discharge for
an AMI. Our 4 comparison groups are as follows: group 1
(early risk), survivors at hospital discharge (n=12 243) further
categorized into either (1) early low-risk survivors without any
of the adverse event end points within 6 weeks of discharge
(n=11 313) and (2) those who developed any of the adverse
event end points within 6 weeks of discharge (n=930). Group
2 (late risk) consists of those who survived the short-term
hospitalization without developing any of the examined end
points at 6 weeks (n=11 313) after hospital discharge,
further categorized into either (1) late low-risk survivors who
did not develop any of the adverse events examined between
6 weeks and 1 year (n=9158) or (2) those who developed any
study-related end point between 6 weeks and 1 year
(n=1920). We compared patient characteristics and risk
factors of being an early and late low-risk survivor (those
without any of the 5 individual study end points) with patients
who developed any of these end points.
We examined the role of traditional risk factors, such as
age, sex, race, and previously diagnosed chronic conditions,
as well as other less conventional risk factors, including
depressive symptoms, functional status, and transition-of-
care processes. Categorical variables were presented as
frequencies, and differences between the respective compar-
ison groups were assessed using the v2 test. Continuous
variables were presented as medians and were compared
using the Wilcoxon rank-sum test. To avoid misclassiﬁcation
because of being unavailable for follow-up, event-free patients
Clinical Perspective
What Is New?
• This study includes a large number of patients hospitalized
with conﬁrmed acute myocardial infarction and collected
relatively novel data on psychosocial factors and indicators
of quality of life.
What Are the Clinical Implications?
• Identifying early and late low-risk survivors who were
discharged from the hospital after an acute myocardial
infarction may help hospital systems and clinicians identify
individuals at different levels of risk for major adverse
clinical events and develop more patient-centered interven-
tions.
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whose last known date to be alive was <365 days after
discharge were excluded from the 1-year analyses (n=235).
Generalized estimating equation models to account for
within-hospital clustering were performed to examine the
association between various demographic and clinical factors
with being a low-risk survivor at the 6-week and 1-year follow-
up periods. The following covariates were included in these
models: age; sex; race (black and other versus white); marital
status; diagnosis of STEMI versus non-STEMI; previously
diagnosed AMI; cerebrovascular disease; peripheral artery
disease; heart failure; atrial ﬁbrillation/ﬂutter; diabetes
mellitus; hypertension, dyslipidemia, or chronic lung disease;
receipt of a prior percutaneous coronary intervention or
coronary artery bypass graft surgery; current smoker; bleed-
ing within the past 6 months; presence of multivessel
coronary artery disease, as determined at cardiac catheter-
ization during the index hospitalization; transfer in from
another short-term care facility; Patient Health Questionnaire-
2 score; EuroQol-5 Dimensions individual components (no
problems versus otherwise); health insurance status; pro-
cesses of care (number of discharge medications, cardiac
rehabilitation referral, and ﬁnancial hardship with medica-
tions); and length of stay during the patient’s index hospital-
ization for AMI.
Results
The study population consisted of 12 243 patients enrolled in
TRANSLATE-ACS from 233 US hospitals between April 2010
and May 2012, who completed the follow-up interviews at
6 weeks and 12 months. Of these patients, 92.4% were
classiﬁed as early low-risk survivors (survived for 6 weeks and
were free from reinfarction, stroke, unplanned coronary
revascularization, or rehospitalization for unstable angina
within 6 weeks after hospital discharge) and 81.0% were
classiﬁed as being late low-risk survivors (those who survived
without any end points at 6 weeks and were free from
reinfarction, stroke, unplanned coronary revascularization, or
rehospitalization for unstable angina at the 1-year follow-up
visit after hospital discharge).
Those remaining free from complications at 6 weeks after
discharge included a greater proportion of men, those who
were married, and those who were less likely to be ﬁrst seen
with a medical history of either diabetes mellitus or stroke
than patients experiencing a composite major adverse cardiac
event (Table 1). Early low-risk survivors were less likely to
have reported mobility or self-care problems, limitations in
usual activities, pain or discomfort, or anxiety/depression
compared with those who developed any of the aggregated
end points examined during this period (Table 1). There were
no differences in the likelihood of developing any of the
examined in-hospital complications between the early low-risk
survivors and the respective comparison group (Table 2).
Early low-risk survivors were signiﬁcantly less likely to have
multivessel coronary artery disease and to have any ﬁnancial
hardships with paying for their cardiac medications (Table 3).
Those remaining free of any of the 5 study end points at
1 year included a greater proportion of men, those who were
married, a lower proportion of blacks, patients who were more
likely to have a job, and those diagnosed as having an STEMI
during their index hospitalization (Table 1). Late low-risk
survivors were less likely to have been previously diagnosed
as having any of the comorbidities examined, with the
exception of bleeding within the past 6 months, and to be a
current smoker. Late low-risk survivors were ﬁrst seen with
higher average glomerular ﬁltration rate ﬁndings and were
signiﬁcantly less likely to have been seen with any of the
limitations or functional impairments examined on the quality-
of-life scale (Table 1). In examining the development of
important in-hospital complications during the patient’s index
hospital admission, similar patterns were observed in both
early and late low-risk survivors (Table 2).
Late low-risk survivors were signiﬁcantly less likely to have
multivessel coronary artery disease and were more likely to
have undergone a percutaneous coronary intervention for
STEMI during their short-term hospitalization. The low-risk
survivors were signiﬁcantly less likely to have any ﬁnancial
hardship with their purchasing of medications compared with
those who developed any of our late study end points
(Table 3).
In a multivariable model examining factors of prognostic
importance, some similarities and important differences were
found between early and late low-risk survivors. Patients who
were male and who were not ﬁrst seen with symptoms of
anxiety and depression were more likely to be low-risk
survivors at 6 weeks or 1 year than the respective compar-
ison groups (Table 4).
On the other hand, several important risk factors were
associated with being a late low-risk survivor. These factors
included not having been previously diagnosed as having most
of the chronic conditions examined, being transferred from
another short-term care facility, having a hospital stay of
≤3 days during the index hospitalization, and not being seen
with any self-care problems or pain/discomfort during the
short-term hospitalization, as assessed by the EuroQol-5
Dimensions (Table 4).
Discussion
The results of this large, multisite, observational study provide
insights into the proportion of patients discharged from the
hospital after an AMI who could be considered to be at low
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Table 1. Patient Characteristics According to the Development of Study End Points During the First 6 Weeks or 1 Year After
Hospital Discharge for an AMI
Characteristics
Early Low-Risk Survivors Late Low Risk-Survivors
No End Point
Development in
6 Weeks
(n=11 313)
Any End Point
Development in
6 Weeks
(n=930)
No End Point
Development in
1 Year
(n=9158)
Any End Point
Development in
1 Year
(n=1920)
Age, y
Median 60.0 59.3* 60.0 60.0
<65 66.5 67.7 67.0 65.4
65–74 21.8 20.9 21.7 21.6
75–84 10.0 9.3 9.6 10.9
≥85 1.8 2.2 1.7 2.1
Male sex 72.4 66.9† 73.8 65.7†
Race
White 88.0 87.4 88.4 85.4†
Black 8.8 10.2 8.2 12.1†
Other 3.2 1.4 3.4 2.5
Hispanic or Latino ethnicity 3.4 3.6 3.6 2.7
No health insurance 14.9 13.3 15.3 12.8*
Married 62.9 59.4 63.8 59.1†
Employed 50.3 48.8 52.4 40.8†
Body mass index, median, kg/m2 29.3 29.5 29.3 29.4
ST-segment elevation myocardial infarction 51.8 53.1 53.3 45.3†
Medical history
Atrial fibrillation 4.6 5.7 4.2 6.1†
Bleeding within past 6 mo 1.1 1.2 1.0 1.4
Coronary bypass surgery 9.1 9.6 7.6 14.0†
Chronic lung disease 9.7 10.4 8.6 15.0†
Current smoker 38.5 36.3 38.4 38.0
Diabetes mellitus 26.1 30.8* 23.9 35.7†
Heart failure 5.8 7.2 4.5 11.5†
Hypertension 66.7 68.7 64.6 76.4†
Hyperlipidemia 65.5 65.6 64.0 72.1†
Myocardial infarction 19.7 18.0 17.9 27.9†
Peripheral artery disease 6.3 6.7 5.3 11.2†
Stroke 5.3 7.3* 4.9 7.2†
Physiologic variables at admission
Blood pressure, median, mm Hg
Systolic 140.0 138.0 140.0 140.0
Diastolic 81.0 80.0 81.0 80.0*
Glomerular filtration rate, median,
mL/min per 1.73 m²
78.3 76.6 79.0 75.6†
Hemoglobin A1C, median, g/dL 6.1 6.2 6.0 6.3†
Low-density lipoprotein,
median, mg/dL
102.0 101.0 103.0 98.0*
Continued
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risk for subsequent adverse events at 2 important time points
after hospital discharge. Insights into the sociodemographic,
psychosocial, and clinical characteristics of those remaining
free from the clinically relevant adverse events we examined
are also provided. Our results may help hospital systems and
clinicians identify individuals at low short- and long-term risk
for major adverse clinical events.
A signiﬁcant proportion of patients were classiﬁed as being
either an early (92%) or late (81%) low-risk survivor in the
present study of >12 000 patients hospitalized with AMI at
233 US medical centers. Few studies have examined the
magnitude of low-risk survivors after hospital discharge for an
AMI, and these studies used different working deﬁnitions of
what constituted a low-risk postdischarge survivor and their
respective follow-up periods.16,17 In a nationwide study of
relatively young (aged <50 years) patients hospitalized with
AMI at all hospitals in Denmark between 1980 and 2009,
early low-risk survivors were deﬁned as patients who survived
at least 30 days after discharge, whereas long-term low-risk
survivors were deﬁned as patients who survived at least
1 month to 1 year after the patient’s index admission.16 The
proportion of low-risk survivors of an AMI increased from 88%
to 97% within 30 days, and from 95% to 98% between 31 and
365 days after being discharged from the hospital during the
years under study. On the other hand, in a study of 144
patients hospitalized with AMI at the University of Pittsburgh
Table 1. Continued
Characteristics
Early Low-Risk Survivors Late Low Risk-Survivors
No End Point
Development in
6 Weeks
(n=11 313)
Any End Point
Development in
6 Weeks
(n=930)
No End Point
Development in
1 Year
(n=9158)
Any End Point
Development in
1 Year
(n=1920)
Quality of life (EuroQoL)
Mobility, no problems 78.0 74.1* 80.0 68.9†
Self-care, no problems 91.9 89.0 92.9 87.2†
Usual activities, no problems 74.2 68.8† 76.0 66.3†
No pain or discomfort 66.1 61.2* 68.1 57.3†
No anxiety/depression 72.5 66.3† 74.0 65.2†
Total score, median 75.0 70.0† 75.0 70.0†
Depression (PHQ-2>3) 7.8 10.8* 7.0 11.5†
Transfer from another short-term care facility 39.6 38.0 40.6 35.4†
Data are given as percentage of each group unless otherwise indicated. AMI indicates acute myocardial infarction; EuroQoL, European quality-of-life scale; PHQ-2, Patient Health
Questionnaire-2.
*Signiﬁcant at P<0.05.
†Signiﬁcant at P<0.001.
Table 2. In-Hospital Complications According to the Development of Study End Points During the First 6 Weeks or 1 Year After
Hospital Discharge for an AMI
Complications
Early Low-Risk Survivors Late Low-Risk Survivors
No End Point
Development
in 6 Weeks
(n=11 313)
Any End Point
Development in
6 Weeks
(n=930)
No End Point
Development
in 1 Year
(n=9158)
Any End Point
Development in
1 Year
(n=1920)
AMI, recurrent 0.6 0.7 0.6 0.7
Cardiogenic shock 1.3 0.7 1.3 1.0
Heart failure 1.6 2.0 1.4 2.2*
Major bleeding episode 3.1 3.4 3.1 3.4
Stroke 0.1 0.1 0.1 0.1
Length of stay, median, d 3.0 3.0† 3.0 3.0
Data are given as percentage of each group unless otherwise indicated. AMI indicates acute myocardial infarction.
*Signiﬁcant at P<0.05.
†Signiﬁcant at P<0.001.
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(Pittsburgh, Pennsylvania) between 1992 and 2000, 56% of
patients who survived the 2-year follow-up period were
classiﬁed as late low-risk survivors.17 Irrespective of differ-
ences in the frequency of low-risk survivors in these different
investigations, which are likely because of the varying follow-
up periods, and in sociodemographic and clinical character-
istics of the study populations (most notably, age and years
under study), further investigation of this important subgroup
of patients is warranted. A considerable proportion of patients
are considered to be at low risk for major adverse clinical
events, during either the short- or longer-term.18 Less
aggressive follow-up plans and clinical care may be needed.
Although we believe that all patients should receive high-
quality transitional care after hospital discharge for an acute
manifestation of a chronic underlying condition, certain
interventions that have been shown to be successful are
resource intensive and costly.18 One way to make the best
use of these limited resources, in the current healthcare
environment, may be to reserve them for patients most likely
to beneﬁt from these resources. For example, we suggest a
more aggressive follow-up, with more frequent follow-up calls
or non–physician providers’ visits, to elderly patients with
several comorbidities during the high-risk transition period
after being released from the hospital after an AMI.
Table 3. Discharge Medications and In-Hospital Cardiac Interventions According to the Development of Study End Points During
the First 6 Weeks or 1 Year After Hospital Discharge for an AMI
Medications at Discharge
Early Low-Risk Survivors Late Low-Risk Survivors
No End Point
Development in
6 Weeks
(n=11 313)
Any End Point
Development in
6 Weeks
(n=930)
No End Point
Development in
1 Year
(n=9158)
Any End Point
Development in
1 Year
(n=1920)
Angiotensin-converting enzyme
inhibitor/angiotensin II receptor blockers
74.2 75.2 74.2 74.2
Anticoagulants 5.3 5.5 4.9 7.0*
Aspirin 98.7 97.8† 98.8 98.2†
b Blockers 93.4 94.1 93.5 92.8
Statins 95.5 94.1 96.1 92.9*
No. of evidence-based cardiac medications
≤2 0.7 1.1 0.5 1.2†
3 5.2 4.7 5.1 6.0
4 28.5 28.4 28.2 29.6
5 65.6 65.8 66.2 63.2
Cardiac interventions and catheterization findings
Cardiac catheterization
Multivessel disease 48.5 56.6* 47.3 54.7*
No. of diseased vessels
1 49.2 41.6* 50.3 42.7*
2 31.3 34.0 31.2 32.0
3 17.2 22.6 16.1 22.7
Coronary bypass surgery 0.3 0.1 0.4 0.2
Multivessel percutaneous coronary intervention 10.9 11.0 10.5 12.1†
Discharge information
Discharged home 97.9 97.7 98.1 97.3*
Cardiac rehabilitation referral 75.8 75.4 75.9 75.1
Follow-up visit scheduled with cardiologist at discharge 41.8 42.0 41.7 42.5
No financial hardship with paying for medication 39.1 31.6† 40.0 37.0*
Data are given as percentage of each group. AMI indicates acute myocardial infarction.
*Signiﬁcant at P<0.001.
†Signiﬁcant at P<0.05.
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Table 4. Factors Associated With Not Developing Study End Points at 6 Weeks or 1 Year After Hospital Discharge for an AMI
Factors
OR (95% Conﬁdence Interval)
Early Low-Risk Survivors
(n=11 313)
Late Low-Risk
Survivors (n=9158)
Age, y
<65 (reference)
65–74 1.16 (0.93–1.45) 1.17 (1.04–1.33)
75–84 1.29 (1.01–1.64) 1.04 (0.88–1.23)
≥85 1.04 (0.63–1.73) 1.10 (0.72–1.69)
Male sex 1.21 (1.02–1.42) 1.24 (1.13–1.37)
Race
White (reference)
Black 0.94 (0.76–1.17) 0.79 (0.67–0.93)
Other 1.47 (0.83–2.61) 1.12 (0.82–1.54)
Hispanic 0.92 (0.63–1.33) 1.47 (1.11–1.93)
Married 1.11 (0.99–1.26) 1.05 (0.94–1.17)
No health insurance vs private 1.19 (0.97–1.46) 1.06 (0.90–1.25)
ST-segment elevation myocardial infarction 0.91 (0.78–1.06) 1.11 (1.00–1.23)
Medical history
Atrial fibrillation 0.81 (0.59–1.09) 1.00 (0.81–1.23)
Bleeding within past 6 mo 0.96 (0.54–1.70) 0.92 (0.59–1.43)
Coronary bypass surgery 1.07 (0.84–1.36) 0.70 (0.58–0.85)
Chronic lung disease 0.99 (0.77–1.26) 0.80 (0.67–0.95)
Current smoker 1.05 (0.73–1.50) 1.01 (0.89–1.14)
Diabetes mellitus 0.87 (0.76–1.01) 0.80 (0.71–0.90)
Heart failure 0.91 (0.67–1.22) 0.73 (0.60–0.89)
Hypertension 1.00 (0.84–1.19) 0.80 (0.72–0.90)
Hyperlipidemia 1.03 (0.88–1.20) 0.96 (0.84–1.10)
Myocardial infarction 1.15 (0.94–1.41) 1.01 (0.87–1.17)
Percutaneous coronary intervention 1.16 (0.94–1.42) 0.78 (0.67–0.92)
Peripheral artery disease 1.06 (0.78–1.43) 0.74 (0.62–0.89)
No. of evidence-based medications per 1-U increase 1.01 (0.91–1.11) 1.10 (1.01–1.19)
Transfer from another short-term care facility 1.04 (0.90–1.21) 1.19 (1.06–1.34)
Depression (PHQ-2>3) 0.85 (0.67–1.09) 0.92 (0.78–1.08)
Length of stay ≥3 d 0.90 (0.79–1.04) 0.83 (0.75–0.91)
Quality of life
Limitations/problems (reference)
Mobility, no problems 0.93 (0.74–1.17) 1.06 (0.92–1.22)
Self-care, no problems 1.09 (0.86–1.38) 1.24 (1.03–1.49)
Usual activities, no problems 1.11 (0.88–1.40) 1.07 (0.94–1.22)
No pain or discomfort 1.09 (0.93–1.26) 1.19 (1.07–1.34)
No anxiety/depression 1.17 (1.03–1.33) 1.20 (1.06–1.36)
Financial hardship paying for medication 0.94 (0.79–1.11) 0.94 (0.82–1.08)
AMI indicates acute myocardial infarction; OR, odds ratio; PHQ-2, Patient Health Questionaire-2.
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Several common risk factors were found among the early
and late low-risk survivors, including being male, being ﬁrst
seen with single-vessel coronary artery disease, and not
having been previously diagnosed as having either diabetes
mellitus or symptoms of anxiety or depression at the patient’s
index hospitalization. Patients who were not ﬁrst seen with
any chronic condition, had an index hospital stay of ≤3 days,
and were not seen with self-care problems or discomfort
during hospitalization were more likely to be late low-risk
survivors than the respective comparison groups.
Few studies have described the clinical epidemiological
characteristics of, or factors associated with, being a low-risk
survivor of an AMI. In theUniversity of Pittsburgh study, patients
who were classiﬁed as being at low risk for adverse events
during the period of follow-up were more likely to have been
diagnosed as having an STEMI and were less likely to have been
previously diagnosed as having heart failure, diabetes mellitus,
hypertension, and chronic obstructive pulmonary disease.17
Similar ﬁndings were reported in an investigation using data
from theWorcester Heart Attack Study, with>4200 residents of
the Worcester, Massachusetts, metropolitan area discharged
after an AMI from 3 central Massachusetts hospitals between
2001 and 2011. The average age of this population was
69 years, 62%weremen, and 92%were white. People classiﬁed
as low-risk survivors were younger (≤65 years) men, were
married, did not have multiple chronic conditions, and did not
develop in-hospital clinical complications.19
Our ﬁndings highlight the greater proportion of men
without various comorbidities in the early and late low-risk
groups. Because patients with greater disease burden are
more likely to experience higher hospital readmission and
death rates than their healthier counterparts, additional
studies focusing on surveillance and treatment approaches
for those with multiple comorbidities remain needed.18
We found several differences between early and late low-
risk survivors and their respective comparison groups on
psychosocial factors, functional status, and transitions of
care, factors that have not been routinely examined in the
prior described studies. Early and late low-risk survivors were
less likely to have previously reported mobility or self-care
problems, limitations in usual activities, pain or discomfort, or
anxiety/depression compared with those who have developed
any of the aggregated end points examined during the
respective follow-up periods.
In a study of >400 consecutive patients who underwent
coronary artery bypass graft surgery between 2008 and 2010
at the University Hospital (Turku, Finland), patients who did not
experience cardiac events during a 6-month follow-up had
higher scores on the EuroQol-5 Dimensions questionnaires
compared with those who experienced a subsequent cardiac
event.20 Other investigators had previously highlighted the
importance of assessing functional limitation as a predictor of
mortality in the general population.12 For example, in an
analysis of data from the National Health and Retirement
Study (n=19 430), as the age of study participants increased,
the association of multiple chronic conditions and 1-year
mortality was attenuated, whereas the association of func-
tional limitations and mortality remained strong.12 Future
studies should consider the inclusion of measures of func-
tional limitation and quality of life when developing risk-
adjustment models and when considering interventions in the
clinical management of people of different ages. For patients
and their caregivers, this prognostic/risk adjustment informa-
tion could be used to inform shared clinical decision making.12
Recent studies have examined the magnitude of, and
factors associated with, various psychosocial factors in
patients hospitalized with AMI.21,22 We found that both early
and late low-risk survivors had lower scores on the Patient
Health Questionnaire-2 than corresponding comparison
groups. An observational study of >1400 patients diagnosed
as having heart failure and multiple chronic medical condi-
tions examined the impact of psychological morbidities on the
healthcare use practices of this patient population.21 Patients
who had a high prevalence of several psychological morbidi-
ties had a signiﬁcantly greater use of the healthcare system
than those without psychological morbidities.21 Similarly, in a
study of >18 000 patients from >40 general practices in
Scotland, potentially preventable and unplanned admissions
to the hospital were highly associated with increasing severity
of physical and psychosocial limitations.22
Given the high frequency and associated burden of
psychosocial vulnerability demonstrated in our study popula-
tion, healthcare providers should consider screening for these
important psychosocial factors in all patients who develop an
AMI. Psychosocial factors have been associated with the
failure to understand and adhere to postdischarge medication
and lifestyle change instructions and worse long-term
outcomes.21,22 These ﬁndings reinforce the importance of
assessing the presence of these psychosocial morbidities by
providers involved in the in-hospital and postdischarge
management of patients with AMI.
The strengths of the present study include the large number
of patients hospitalized with conﬁrmed AMI and the collection
of relatively novel data on psychosocial factors and indicators
of quality of life. On the other hand, we did not have information
available on other factors that have previously been associated
with an increased risk of readmission or death after an AMI,
including patient’s adherence to prescribed cardiac medica-
tions after hospital discharge or changes in their disease,
functional, or cognitive status. Furthermore, because of the
characteristics of the study population (namely, patients
hospitalized with an AMI who underwent a percutaneous
coronary intervention), our ﬁndings might not apply to the
general population of patients hospitalized with an AMI.
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Identifying early and late low-risk survivors who were
discharged from the hospital after an AMI may help hospital
systems and clinicians identify individuals at different levels
of risk for major adverse clinical events and develop more
patient-centered interventions. Furthermore, given the high
frequency and associated burden of functional limitations
and psychosocial vulnerability demonstrated in our study
population, healthcare providers should consider screening
for these important risk factors in all patients who develop
an AMI.
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